Alex Aronov received his PhD in chemistry from the University of Washington, and completed his postdoctoral training in computer-aided drug design (CADD) at UCSF. He started his industrial career in 2001 as a CADD scientist within the drug discovery unit of Vertex Pharmaceuticals in Cambridge, MA, involved in projects across a range of therapeutic areas from oncology to inflammation, and from rare diseases to antivirals. From 2007 to 2012, he led a cross-functional team to deliver a novel immune-oncology therapy BVD-723. He later led the Research Informatics at Vertex, with responsibility for Vertex’s global informatics efforts. He currently leads Vertex’s Enterprise Data Science team, working with stakeholders across the business to deliver data-driven solutions. Alex is an author of over 30 peer-reviewed manuscripts, and is an inventor on over 40 international patent applications. He holds an MBA from MIT Sloan.